Markets:

Overview

News

Currencies

International

Treasuries

Mesoblast Limited - American Depositary Shares (NQ:MESO)

15.74 -0.44 (-2.72%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mesoblast Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 14, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

December 14, 2021

Gainers Exicure, Inc. (NASDAQ: XCUR) rose 41.8% to $0.3830. Exicure’s Audit Committee recently concluded that Grant Corbett misreported raw data from certain R&D...

Via Benzinga

Why Mesoblast Shares Are Falling ↗

December 14, 2021

Mesoblast Limited (NASDAQ: MESO) shares are trading lower after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 14, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX) stock increased by 134.05% to $3.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Mesoblast's Heart Failure Candidate Shows Treatment Benefit In High-Risk Patients ↗

December 06, 2021

Mesoblast Limited (NASDAQ: MESO) announced new analyses from the landmark DREAM-HF Phase 3 trial of rexlemestrocel-L in HFrEF patients with diabetes and/or ischemia...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 03, 2021

Gainers Lixte Biotech Holdings (NASDAQ:LIXT

Via Benzinga

Mesoblast Announces Debt Refinancing And Expansion With Oaktree Capital ↗

November 22, 2021

Mesoblast Limited (NASDAQ: MESO) refinanced its existing senior debt facility with a new $90 million five-year facility provided by Oaktree Capital Management...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 15, 2021

Gainers Tricida (NASDAQ:TCDA) shares rose...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 15, 2021

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Mesoblast's Remestemcel Shows Promising Action In Patients With Heart Failure ↗

November 15, 2021

Mesoblast Limited (NASDAQ: MESO) presented new results from the landmark Phase 3 study of rexlemestrocel-L in 565 patients with chronic heart failure (CHF) with...

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

September 01, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands Group, Inc. (NASDAQ:...

Via Benzinga

54 Biggest Movers From Yesterday ↗

September 02, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 01, 2021

Gainers GBS (NASDAQ:GBS) stock moved upwards by 51.23% to $4.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $60.6 million...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

September 01, 2021

Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-...

Via Benzinga

55 Biggest Movers From Yesterday ↗

September 01, 2021

Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it...

Via Benzinga

Why Mesoblast Stock Is Plunging After Q4 Earnings Report? ↗

August 31, 2021

Mesoblast Limited (NASDAQ: MESO) shares dived on Tuesday as the FDA raised more questions around its flagship drug candidate, and its annual loss widened. ...

Via Benzinga

33 Stocks Moving In Tuesday's Mid-Day Session ↗

August 31, 2021

Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2...

Via Benzinga

Mesoblast (MESO) Q3 2021 Earnings Call Transcript ↗

August 31, 2021

MESO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Mesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trial ↗

July 19, 2021

Mesoblast Limited (NASDAQ: MESO) has announced the presentation of 90-day survival outcomes from the remestemcel-L trial in ventilator-dependent COVID-19 patients...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 60.76% to $2.09 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Mesoblast Updates On Rexlemestrocel-L Program In Chronic Low Back Pain ↗

July 01, 2021

Mesoblast Limited (NASDAQ: MESO) provided an update on the strategy for bringing rexlemestrocel-L to patients in the U.S. with chronic low back pain (CLBP) due to...

Via Benzinga

Mesoblast (MESO) Q3 2021 Earnings Call Transcript ↗

June 03, 2021

MESO earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout ↗

June 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.